Theanine, a compound found in tea, is increasingly being discussed as a potential aid for sleep, prompting a closer look at the scientific evidence supporting its use, particularly for younger populations. While melatonin and magnesium supplements are more frequently inquired about in clinical settings, L-theanine (technically L-γ-glutamylethylamide, N5-ethyl-L-glutamine, or γ-glutamylethylamide) remains a subject of parental concern and interest. This investigation aims to dissect the available research to determine the efficacy and safety of theanine for children and teenagers struggling with sleep disturbances.
It is crucial to preface this discussion with a significant caveat: the vast majority of children experiencing insomnia do not require pharmacological interventions or dietary supplements. Behavioral approaches, such as structured sleep hygiene practices and, for older children and adolescents, Cognitive Behavioral Therapy for Insomnia (CBT-I), are often the most effective and recommended first-line treatments. Parents concerned about their child’s sleep patterns should consult with their pediatrician for a comprehensive evaluation and personalized guidance.
The Origin of Interest in Theanine
The exploration into theanine’s sleep-promoting properties was sparked by a deep dive into the research landscape of sleep aids. While reviewing an extensive article on melatonin preparations from ConsumerLab, a reputable organization known for its third-party testing of supplements and provision of evidence-based advice, the focus shifted to other supplements listed in the sleep category. Among these, L-theanine emerged, with initial discussions highlighting its potential to address issues such as middle-of-the-night awakenings and anxiety. For some, personal experience with these sleep disruptions, potentially linked to specific studies or stressors, led to an individual trial of theanine. While initial personal observations may suggest a benefit, a rigorous, long-term assessment, potentially involving controlled trials or objective data tracking, is necessary to substantiate these subjective improvements.
The Regulatory Landscape of Dietary Supplements
The ease with which supplements like theanine can reach the market is largely attributed to the Dietary Supplement Health and Education Act (DSHEA) of 1994. This legislation shifted the regulatory burden, requiring the Food and Drug Administration (FDA) to prove a supplement is unsafe rather than requiring manufacturers to demonstrate safety and efficacy before marketing. Consequently, many supplements enter the market with limited or no robust scientific research substantiating their claimed benefits, creating a complex environment for consumers seeking reliable information.
Understanding L-Theanine: What It Is and How It Works
L-theanine is a water-soluble amino acid, a fundamental building block of proteins, naturally found in black and green teas. Unlike essential amino acids, it is not a dietary requirement for survival. Once ingested, L-theanine is absorbed into the bloodstream and can cross the blood-brain barrier, where it appears to influence the levels of key neurotransmitters. Notably, it seems to modulate neurotransmitters associated with relaxation, such as gamma-aminobutyric acid (GABA), a primary inhibitory neurotransmitter in the central nervous system.
Potential Benefits: Focus on Sleep and Relaxation
Theanine has been investigated for its potential benefits in both cognitive function and sleep. However, the primary focus of current research, and this analysis, is on its sleep-related effects. Preclinical and some human studies suggest that theanine can induce relaxation by promoting alpha brain waves, which are associated with a calm and alert state. Additionally, it has been observed to lower heart rate, blood pressure, and cortisol levels, all physiological markers indicative of reduced stress and enhanced relaxation.
Evidence for Sleep Benefits in Adults
The scientific literature on L-theanine’s sleep benefits has been significantly advanced by two recent systematic reviews. The first, a meta-analysis by Bulman et al. (2025), statistically analyzed data from 19 randomized controlled trials (RCTs) involving 897 participants. The second, a systematic review by Cotter et al. (2026), examined 13 trials with 550 participants. It is noteworthy that the authors of the Cotter review are employed by The Water Street Collective, a company that markets L-theanine products, a potential conflict of interest that warrants consideration.
The Bulman meta-analysis identified a benefit in subjective sleep onset latency, meaning individuals reported falling asleep faster. However, objective measures of sleep onset latency did not show a significant effect. For sleep maintenance, the meta-analysis found no significant effect, though there was a trend towards improvement (p=0.10). Sleep efficiency, the proportion of time spent asleep while in bed, showed no effect in the initial analysis but became significant after the removal of one outlier study. Overall subjective sleep quality demonstrated a moderate benefit (SMD 0.43) according to Bulman et al. The review also indicated a benefit in reducing daytime dysfunction (SMD 0.33, p<0.001), a measure assessing the impact of sleep problems on daily activities and energy levels, derived from the Pittsburgh Sleep Quality Index (PSQI).
The Cotter systematic review also reported benefits across several sleep domains. They found a benefit in sleep onset latency and sleep maintenance, with actigraphy data showing reduced wake after sleep onset (WASO). Sleep efficiency also showed improvement, with approximately a 3-4% increase in two trials. Overall sleep quality was consistently reported as better across various assessment tools, including the PSQI and the Overlap Sleep Assessment (OSA). Participants also reported improved sleep satisfaction and refreshment, experiencing better recovery upon waking.
A critical distinction between the two reviews lies in their inclusion criteria. The Bulman meta-analysis included 11 studies where L-theanine was combined with other active ingredients (such as valerian, magnesium, or casein hydrolysate), potentially confounding the attribution of effects solely to L-theanine. In contrast, the Cotter review excluded all combination products, focusing on studies where L-theanine was administered alone. Both reviews converged on the finding that consistent effects were observed at doses of 200-450 mg per day, typically taken before bedtime.
In summary, the current evidence suggests that L-theanine may improve individuals’ subjective perception of sleep quality, leading to a feeling of better rest without necessarily increasing total sleep duration. This perceived improvement in sleep quality appears to translate into tangible benefits in daytime functioning, as evidenced by the reduction in daytime dysfunction measures. This finding is considered one of the most robust outcomes reported in the Bulman et al. meta-analysis.
Sleep Benefits in Children and Adolescents: A Limited Evidence Base
Similar to the situation with magnesium, research specifically investigating the effects of L-theanine on sleep in children and adolescents is notably scarce. The available studies are limited in number and scope, with most focusing on specific pediatric populations.
ADHD and L-Theanine
One notable study examined the impact of L-theanine on sleep quality in boys diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Conducted by Lyon et al. in 2011, this single trial involved 9-year-old boys (mean age 9.45 years) who received 400 mg of theanine daily. The study reported significant improvements in sleep efficiency and a reduction in nighttime movements. The trial was designed as a placebo-controlled, double-blind study, which are considered strong methodologies.
However, this study is subject to several critical limitations that temper its conclusions. The FDA reviewed this study in 2024 and identified concerns, including the lack of a clearly defined primary endpoint, the absence of a conventional statistical analysis plan, and results that did not meet their own pre-specified significance thresholds. Furthermore, baseline sleep measurements were not reported, the study population consisted exclusively of boys, and the potential influence of stimulant medications, known to affect sleep, was not analyzed. Parent-reported sleep questionnaire data was collected but not discussed in the study’s findings. Additionally, the research was funded by the manufacturer of the L-theanine product used, which raises questions about potential bias.
Autism Spectrum Disorder and L-Theanine
Another study, Hannant et al. (2021), explored the effects of different types of tea (Oolong, green tea, and a control) on various domains in nine children with Autism Spectrum Disorder (ASD). Green tea is known for its higher theanine content. While the study included treatments with both GABA and theanine, the results, as interpreted, did not demonstrate significant changes in sleep or cortisol levels for either tea intervention compared to the control. The limitations of this study include its small sample size and the inherent difficulty in isolating the effects of theanine when combined with other compounds found in tea.
Concerns and Potential Issues with L-Theanine
While L-theanine is generally considered to have a good safety profile, and the majority of trials have reported minimal side effects, there are important considerations. No documented drug interactions between theanine and other medications have been identified. However, caution is advised when using it in conjunction with other sleep-promoting medications or medications for blood pressure, as theanine can potentially lower blood pressure.
The overarching issue remains the sparse and often inconclusive evidence base, particularly concerning its use in pediatric populations. The FDA’s 2024 review of theanine for pharmaceutical use concluded that there was insufficient evidence to support its application in compounded medications, underscoring the need for more rigorous research.
Dosing Recommendations
The systematic reviews by Bulman et al. and Cotter et al. consistently suggest an optimal daily dose of L-theanine for adults ranging from 200 to 450 mg, typically administered before bedtime. However, there are no established weight-based pediatric dosing guidelines for L-theanine. This lack of specific guidance for children further reinforces the cautious approach to its use in this demographic.
Conclusion: A Measured Approach to Theanine for Sleep
L-theanine is a popular supplement that garners significant attention within the sleep health discourse. While it appears to be reasonably safe for adults, the evidence supporting its efficacy in children is currently insufficient, with only one primary study directly addressing its use in this age group, and that study carries significant methodological caveats.
For adults experiencing mild insomnia or anxiety, L-theanine may be a reasonable option to consider, given the existing research suggesting potential benefits. However, the decision to use any supplement, especially for children, should always be made in consultation with a healthcare professional. A thorough discussion with a pediatrician is paramount to ensure that all potential risks and benefits are weighed appropriately, and that the most effective and evidence-based strategies for addressing sleep concerns are prioritized.
Bibliography
- Bulman, S. E., et al. (2025). A Meta-Analysis of L-Theanine’s Effects on Sleep. [Journal Name and details to be inserted upon publication]
- Cotter, E., et al. (2026). Theanine and Sleep: A Systematic Review. [Journal Name and details to be inserted upon publication]
- Hannant, P., et al. (2021). [Study title on tea and ASD]. [Journal Name and details to be inserted upon publication]
- Lyon, N. R., et al. (2011). The effects of L-theanine on sleep quality in boys with ADHD. [Journal Name and details to be inserted upon publication]
Originally published April 2026. Last reviewed/updated by Dr. Craig Canapari, MD in May 2026
